Christopher T. Gerard
Net Worth
Last updated:
What is Christopher T. Gerard net worth?
The estimated net worth of Mr. Christopher T. Gerard is at least $18,187,906 as of 2 Aug 2021. He owns shares worth $3,823,456 as insider, has earned $5,054,450 from insider trading and has received compensation worth at least $9,310,000 in Amedisys, Inc..
What is the salary of Christopher T. Gerard?
Mr. Christopher T. Gerard salary is $1,330,000 per year as Pres, Chief Operating Officer & Director in Amedisys, Inc..
How old is Christopher T. Gerard?
Mr. Christopher T. Gerard is 58 years old, born in 1967.
What stocks does Christopher T. Gerard currently own?
As insider, Mr. Christopher T. Gerard owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Amedisys, Inc. (AMED) | Pres, Chief Operating Officer & Director | 37,856 | $101 | $3,823,456 |
What does Amedisys, Inc. do?
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Christopher T. Gerard insider trading
Amedisys, Inc.
Mr. Christopher T. Gerard has made 26 insider trades between 2018-2021, according to the Form 4 filled with the SEC. Most recently he sold 1,250 units of AMED stock worth $325,944 on 2 Aug 2021.
The largest trade he's ever made was exercising 17,496 units of AMED stock on 12 Feb 2020. As of 2 Aug 2021 he still owns at least 37,856 units of AMED stock.
Amedisys key executives
Amedisys, Inc. executives and other stock owners filed with the SEC:
- Mr. Christopher T. Gerard (58) Pres, Chief Operating Officer & Director
- Mr. David L. Kemmerly (62) Chief Legal & Gov. Affairs Officer
- Mr. Paul Berthold Kusserow (64) Chairman & Chief Executive Officer
- Mr. Scott G. Ginn (56) Executive Vice President & Chief Financial Officer
- Ms. Sharon Brunecz (58) Chief HR Officer